Zoekresultaten - Portaal voor medische datamodellen (MDM-portaal)

Zoekresultaten filteren
Datamodellen selecteren

Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

124 Zoekresultaten.

Head and Neck Cancer NCT00588770 Eligibility - E1305 Registration Worksheet (step 1) - 2750715v1.0 - E1305 Registration Worksheet (step 1)

- 17-09-21 - 1 Formulier, 1 Itemgroep, 14 Data-elementen, 1 Taal

Itemgroep: Eligibility

E1305 Registration Worksheet (step 1) Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4D9A0B72-1D0D-5E28-E044-0003BA3F9857

Head and Neck Cancer NCT01084083 Eligibility - Registration Worksheet for E1308 (Step 1) - 2924700v1.0 - Registration Worksheet for E1308 (Step 1)

- 17-09-21 - 1 Formulier, 4 Itemgroepen, 25 Data-elementen, 1 Taal

Itemgroepen: Eligibility, Patient Demographics / Pre-Treatment Characteristics, Footer, Footer

Registration Worksheet for E1308 (Step 1) Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6FCB8806-CC72-7795-E040-BB89AD43466D

Head and Neck Cancer NCT01084083 Eligibility - Registration Worsksheet for E1308 (Step 0) - 2922435v1.0 - Registration Worsksheet for E1308 (Step 0)

- 17-09-21 - 1 Formulier, 2 Itemgroepen, 30 Data-elementen, 1 Taal

Itemgroepen: Eligibility, Patient Demographics / Pre-Treatment Characteristics

Registration Worsksheet for E1308 (Step 0) Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6F7AB198-2739-A0A1-E040-BB89AD43458F

Head and Neck Cancer NCT00956007 Registration - RTOG 0920 OPEN Registration Worksheet - Step 2 - 3219537v1.0 - RTOG 0920 OPEN Registration Worksheet - Step 2

- 17-09-21 - 1 Formulier, 2 Itemgroepen, 17 Data-elementen, 1 Taal

Itemgroepen: Patient Information 1, Patient Information

RTOG 0920 OPEN Registration Worksheet - Step 2 Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A0190014-3FCB-4E42-E040-BB89AD43786E

Head and Neck Cancer NCT00956007 Registration - RTOG 0920 OPEN Registration Worksheet - 3219099v1.0 - RTOG 0920 OPEN Registration Worksheet

- 17-09-21 - 1 Formulier, 4 Itemgroepen, 22 Data-elementen, 1 Taal

Itemgroepen: Patient Information 1, Demographics, Patient Information, Eligibility

RTOG 0920 OPEN Registration Worksheet Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9FDDB442-DA44-C42C-E040-BB89AD432DB7

Eligibility Squamous Cell Carcinoma of the Head and Neck NCT01528163

- 17-09-21 - 1 Formulier, 2 Itemgroepen, 26 Data-elementen, 1 Taal

Itemgroepen: Inclusion Criteria, Exclusion Criteria

Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck; ODM derived from: https://clinicaltrials.gov/show/NCT01528163

NCT01302834 Quality of Life - RTOG 1016 QL35: Radiation Therapy Oncology Group Phase III Head and Neck Cancer EORTC-QLQ-H&N35 - 3159340v1.0 - RTOG 1016 QL35: Radiation Therapy Oncology Group Phase III Head and Neck Cancer EORTC-QLQ-H&N35

- 17-09-21 - 1 Formulier, 5 Itemgroepen, 42 Data-elementen, 1 Taal

Itemgroepen: Header Module, EORTC QLQ-H&N35, EORTC QLQ-H&N35 (cont), EORTC QLQ-H&N35 (cont2), EORTC QLQ-H&N35 (cont3)

RTOG 1016 QL35: Radiation Therapy Oncology Group Phase III Head and Neck Cancer EORTC-QLQ-H&N35 Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=95322CC4-A66C-8D67-E040-BB89AD431C52

NCT01302834 Quality of Life - RTOG 1016 FQ: Radiation Therapy Oncology Group Phase III Head and Neck Cancer Work Status Questionnaire - 3160066v1.0 - RTOG 1016 FQ: Radiation Therapy Oncology Group Phase III Head and Neck Cancer Work Status Questionnaire

- 17-09-21 - 1 Formulier, 2 Itemgroepen, 29 Data-elementen, 1 Taal

Itemgroepen: Header Module, Work Status Questionnaire

RTOG 1016 FQ: Radiation Therapy Oncology Group Phase III Head and Neck Cancer Work Status Questionnaire Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=953353B4-562C-83C2-E040-BB89AD433EAB

Eligibility Squamous Cell Carcinoma of the Head and Neck NCT02454179

- 28-05-21 - 1 Formulier, 2 Itemgroepen, 8 Data-elementen, 1 Taal

Itemgroepen: Inclusion Criteria, Exclusion Criteria

Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Advanced Head and Neck Squamous Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02454179

Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract NCT01175499 - Eligibility

- 17-04-19 - 1 Formulier, 2 Itemgroepen, 10 Data-elementen, 1 Taal

Itemgroepen: Inclusion Criteria, Exclusion Criteria

This study will compare TNFE-NBI and biopsy, with DRE and biopsy for the diagnostic evaluation and staging of patients with suspicious UADT lesions. All patients enrolled in the study will undergo TNFE-NBI with biopsy of suspicious lesions prior to planned regular clinical care (DRE). Biopsies will be evaluated by standard clinical methods for patient diagnoses and care. As the current standard of care, if all biopsies for a given patient are non-malignant, a 3 month office visit will be arranged to evaluate and determine the need for further intervention. At the end of study enrollment both sets of biopsies will be re-evaluated in a blinded fashion by the surgical pathologist. Study assessment of malignant vs. non-malignant (benign) pathology will be used to see whether both tests tended to agree on diagnoses. ODM derived from: https://clinicaltrials.gov/show/NCT01175499

Head and Neck Cancer NCT00265941 Follow-Up - Follow-up Head and Neck Cancer RTOG-0522 F1 NCT00265941

- 05-02-19 - 1 Formulier, 8 Itemgroepen, 66 Data-elementen, 1 Taal

Itemgroepen: Header, CURRENT DISEASE STATUS AND METHOD OF DETERMINATION, DISEASE EVENTS, New primary cancer, Non-Protocol Therapy, Swallowing and Tube Feeding, Protocol Specific Adverse Event Evaluation, Other Adverse Events

RTOG-0522 F1: Follow-up Form Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer NCT00265941 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F65D686D-87BE-6280-E034-0003BA3F9857

Eligibility Squamous Head and Neck Cancer NCT01283178

- 14-09-18 - 1 Formulier, 2 Itemgroepen, 17 Data-elementen, 1 Taal

Itemgroepen: Inclusion Criteria, Exclusion Criteria

Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC; ODM derived from: https://clinicaltrials.gov/show/NCT01283178 Sponsor: Virginia Commonwealth University Collaborator: National Cancer Institute (NCI) Principal Investigator: Shiyu Song Virginia Commonwealth University

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.